01:12 , Nov 18, 2016 |  BC Extra  |  Company News

Management tracks

Diagnostics company Exact Sciences Corp. (NASDAQ:EXAS) promoted Jeff Elliott to CFO from VP of business development and strategy. He replaces the retiring John Bakewell. Neurology company vasopharm GmbH (Wuerzburg, Germany) named Irina Antonijevic CMO, a newly...
20:45 , Nov 1, 2016 |  BC Extra  |  Financial News

Acesion raises EUR 9.1M in series A

Cardiology company Acesion Pharma ApS (Copenhagen, Denmark) raised EUR 9.1 million ($10 million) in a series A round from existing investors Novo Seeds and the Wellcome Trust. CEO Frans Wuite told BioCentury the company hopes...
08:00 , Dec 22, 2014 |  BC Week In Review  |  Financial News

Acesion Pharma completes venture financing

Acesion Pharma ApS, Copenhagen, Denmark   Business: Cardiovascular   Date completed: 2014-12-17   Type: Venture financing   Raised: DKK15.2 million ($2.5 million)   Investors: Novo Seeds; Broadview Ventures Inc.   ...
07:00 , Sep 1, 2014 |  BC Week In Review  |  Company News

Acesion Pharma board of directors update

Acesion Pharma ApS, Copenhagen, Denmark   Business: Cardiovascular   Appointed: Ingelise Saunders as chairman, currently a director at Leo Pharma A/S and chairman of MinervaX ApS   ...
08:00 , Dec 19, 2013 |  BC Innovations  |  Distillery Techniques

Technology: Disease models

Approach Summary Licensing status Publication and contact information Disease models Pten (Mmac1; Tep1)-mutant mouse model of autism Mice with a heterozygous, autism-linked Pten deletion could be used to screen...
07:00 , Jun 24, 2013 |  BC Week In Review  |  Company News

Acesion Pharma, The Wellcome Trust cardiovascular news

Acesion received a DKK27.9 million ($5 million) Seeding Drug Discovery award from the Wellcome Trust to fund a program to identify and develop a small molecule inhibitor of SK channels to treat acute atrial fibrillation....
07:00 , Mar 18, 2013 |  BioCentury  |  Emerging Company Profile

Acesion: Accessing SK in AF

Acesion Pharma ApS is going after a new target in atrial fibrillation - SK channels. The NeuroSearch A/S spinout expects its small molecule inhibitors to have fewer side effects than marketed AF drugs. Marketed drugs for...
08:00 , Dec 19, 2011 |  BC Week In Review  |  Company News

NeuroSearch cardiovascular news

NeuroSearch will spin out newco Acesion Pharma ApS to focus on developing products to treat atrial fibrillation (AF) based on NeuroSearch's sodium and potassium ion channels program. Acesion will receive an option to license...